LAVILavipharm S.A.

ATH · GR · Healthcare · Drug Manufacturers - Specialty & Generic · lavipharm.com

1.564EUR+0.64%Mkt Cap: 290.32M $P/E: 52.133d ago

Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally. …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap290.32M $

Enterprise Value316.36M $

Revenue (TTM)70.15M $

Gross Profit32.94M $

Net Income (TTM)6.51M $

Revenue/Share0.4152 USD

Last Price1.564 EUR

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees285

CountryGR

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)52.13

P/E (Forward)—

PEG—

EV/EBITDA21.88

EV/Revenue4.51

P/S4.14

P/B4.68

EPS (TTM)0.03

EPS (Forward)—

52W Range

0.756083% of range1.734

52W High1.734 EUR

52W Low0.7560 EUR

Profitability

Gross Margin48.42%

Oper. Margin12.49%

EBITDA Margin20.61%

Profit Margin9.56%

ROE10.61%

ROA4.60%

Growth

Revenue Growth15.40%

Earnings Growth-37.70%

Cash Flow & Leverage

Operating CF7.25M $

CapEx (TTM)5.02M $

FCF Margin—

FCF Yield—

Net Debt28.99M $

Net Debt/EBITDA2.01

Balance Sheet

Debt/Equity0.58

Current Ratio—

Quick Ratio—

Book Value/Sh0.3340 EUR

Cash/Share0.0360 EUR

Dividends

Fwd Div Rate0.0200 EUR

Trail. Div Rate0.0000 EUR

Div. Yield1.28%

5Y Avg Yield2.38%

Payout Ratio68.49%

Ex-Div DateJul 20, 2026

Pay DateNov 8, 1995

Splits

Last Split1:3

Split DateAug 1, 2022

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.170.78M

Float—

Insiders61.09%

Institutions1.04%

Technical

SMA 501.538 (+1.7%)

SMA 2001.293 (+21.0%)

Beta1.00

S&P 52W Chg19.18%

Avg Vol (30d)59.42K

Avg Vol (10d)19.27K

Technical Indicators

RSI (14)52.8

MACD0.0097

MACD Signal0.0124

MACD Hist.-0.0027

BB Upper1.645 EUR

BB Middle1.571 EUR

BB Lower1.496 EUR

BB Width9.47%

ATR (14)0.0424 EUR

Vol Ratio (20d)0.49x